drugset

drugset / Trial / NCT00816829

Effect of Fenofibrate on Sleep Apnea Syndrome

NCT00816829 ↗

Phase 2 Terminated 34 enrolled Solvay Pharmaceuticals

RandomizedParallel-groupTriple-blindTreatment

Summary

Objectives: to investigate for the potential effect of fenofibrate on symptoms and biological changes associated with sleep apnea syndrome.

Timeline

Start: 2005-09
Primary completion: 2008-01
Completion: 2008-01

Publications

Bruckert E, Duchene E, Bonnefont-Rousselot D, Hansel B, Ansquer JC, Dubois A, Gaymard B. Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome? Curr Med Res Opin. 2010 May;26(5):1185-92. doi: 10.1185/03007991003693581.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fenofibrate	Small molecule	145 mg	—

Indications